Follow
John M McLaughlin
John M McLaughlin
Vice President, Pfizer
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in …
EJ Haas, FJ Angulo, JM McLaughlin, E Anis, SR Singer, F Khan, N Brooks, ...
The Lancet 397 (10287), 1819-1829, 2021
16822021
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
SY Tartof, JM Slezak, H Fischer, V Hong, BK Ackerson, ON Ranasinghe, ...
The Lancet 398 (10309), 1407-1416, 2021
11822021
Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer
JM McLaughlin, RT Anderson, AK Ferketich, EE Seiber, R Balkrishnan, ...
Journal of Clinical Oncology 30 (36), 4493, 2012
2422012
A multicenter study of ICU telemedicine reengineering of adult critical care
CM Lilly, JM McLaughlin, H Zhao, SP Baker, S Cody, RS Irwin, ...
Chest 145 (3), 500-507, 2014
2242014
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience
ED Paskett, KW Reeves, JM McLaughlin, ML Katz, AS McAlearney, ...
Contemporary clinical trials 29 (6), 847-861, 2008
2172008
Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: a test-negative design
JM McLaughlin, Q Jiang, RE Isturiz, HL Sings, DL Swerdlow, BD Gessner, ...
Clinical Infectious Diseases 67 (10), 1498-1506, 2018
1702018
Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013
JM McLaughlin, JJ McGinnis, L Tan, A Mercatante, J Fortuna
The journal of primary prevention 36, 259-273, 2015
1652015
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative …
SY Tartof, JM Slezak, L Puzniak, V Hong, F Xie, BK Ackerson, SR Valluri, ...
The Lancet Respiratory Medicine 10 (7), 689-699, 2022
1242022
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective …
EJ Haas, JM McLaughlin, F Khan, FJ Angulo, E Anis, M Lipsitch, ...
The Lancet Infectious Diseases 22 (3), 357-366, 2022
1152022
Severity of Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom
C Hyams, R Challen, R Marlow, J Nguyen, E Begier, J Southern, J King, ...
The Lancet Regional Health–Europe 25, 2023
1062023
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study
SY Tartof, JM Slezak, L Puzniak, V Hong, TB Frankland, BK Ackerson, ...
The Lancet Regional Health–Americas 9, 2022
982022
Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of observational studies
HL Sings, P De Wals, BD Gessner, R Isturiz, C Laferriere, JM McLaughlin, ...
Clinical Infectious Diseases 68 (12), 2135-2143, 2019
922019
Identification of Cryptosporidium oocysts by monoclonal antibody.
JM McLaughlin, DP Casemore, TG Harrison, PJ Gerson, D Samuel, ...
861987
Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the …
ED Paskett, JM McLaughlin, PL Reiter, AM Lehman, DA Rhoda, ML Katz, ...
Preventive medicine 50 (1-2), 74-80, 2010
852010
Evaluating the efficacy of lay health advisors for increasing risk-appropriate Pap test screening: a randomized controlled trial among Ohio Appalachian women
ED Paskett, JM McLaughlin, AM Lehman, ML Katz, CM Tatum, JM Oliveri
Cancer Epidemiology, Biomarkers & Prevention 20 (5), 835-843, 2011
742011
Rates of medically attended RSV among US adults: a systematic review and meta-analysis
JM McLaughlin, F Khan, E Begier, DL Swerdlow, L Jodar, AR Falsey
Open forum infectious diseases 9 (7), ofac300, 2022
712022
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia
RE Isturiz, J Ramirez, WH Self, CG Grijalva, FL Counselman, G Volturo, ...
Vaccine 37 (25), 3352-3361, 2019
682019
Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma
HS Friedman, P Navaratnam, J McLaughlin
Journal of Asthma 47 (9), 994-1000, 2010
612010
Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia
JM McLaughlin, ML Witkop, A Lambing, TL Anderson, J Munn, B Tortella
Haemophilia 20 (4), 506-512, 2014
592014
Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis
JM McLaughlin, Q Jiang, BD Gessner, DL Swerdlow, HL Sings, RE Isturiz, ...
Vaccine 37 (43), 6310-6316, 2019
552019
The system can't perform the operation now. Try again later.
Articles 1–20